术前贫血对外周动脉疾病行血管内治疗患者住院、死亡及总生存的影响:美国与加拿大回顾性队列研究
该回顾性队列研究查询美国与加拿大国家血管质量倡议数据库(2010—2019年),纳入79 707例因外周动脉疾病行血管内外周血管介入(PVI)的成年患者,按术前血红蛋白水平将贫血分为轻度、中度、重度。结果显示,术前贫血的存在及程度与30天死亡率升高、住院时间延长及总生存下降独立相关。
要点
- 术前贫血见于38 543例(48%),其中轻度27 435例(71%)、中度9783例(25%)、重度1325例(4%)。
- 术前贫血的存在与程度和30天死亡率升高、住院时间延长及总生存下降独立相关。
- Kaplan-Meier生存分析显示死亡与贫血程度相关(p<0.001)。
核心结论
- 术前贫血的存在及程度与外周动脉疾病行血管内PVI患者的30天死亡率升高、住院时间延长及总生存下降独立相关。
研究设计与样本
- 美国与加拿大回顾性队列研究,查询国家血管质量倡议数据库2010—2019年全部血管内PVI,共纳入79 707例符合标准的成年患者,平均年龄68岁,男性占59%。
- 贫血分级:轻度为男性Hb=10-13 g/dL、女性Hb=10-12 g/dL,中度为Hb=8-9.9 g/dL,重度为Hb<8 g/dL。
- 中位随访时间4年(范围1.25-5.78年)。
主要发现
- 贫血见于38 543例(48%),其中轻度27 435例(71%)、中度9783例(25%)、重度1325例(4%)。
- 单因素分析中,30天死亡率、总住院时间及总生存与术前贫血程度显著相关。
关键数值与推荐
- Kaplan-Meier生存分析显示死亡与贫血程度相关(p<0.001)。
临床怎么用
- 作者认为,该结果有助于对行外周血管介入的患者进行准确的术前风险分层,并可能降低术后住院时间相关的医疗支出,同时维持医疗质量与患者安全。
- 作者认为,该结果可为临床试验提供指导,未来前瞻性试验应评估术前优化血红蛋白作为可能可改变的风险因素对结局的影响。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Preoperative anemia is associated with adverse outcomes after cardiac and noncardiac surgeries, but outcomes after an endovascular peripheral vascular intervention (PVI) are not well established. We aimed to assess the association of preoperative anemia with 30 day death, hospital length of stay (LOS), and overall (long term) survival in patients undergoing an endovascular PVI for peripheral artery disease. MATERIALS AND METHODS: In this retrospective, cohort study in the United States and Canada, we queried the national Vascular Quality Initiative database for all endovascular PVIs performed between 2010 and 2019, and outcomes were correlated with patients' hemoglobin (Hb) levels. Anemia was classified as mild (Hb=10-13 g/dL for men and 10-12 g/dL for women), moderate (Hb=8-9.9 g/dL), and severe (Hb<8 g/dL). RESULTS: A total of 79 707 adult patients who met study criteria underwent endovascular PVI. The mean age was 68 years, and 59% of patients were male. Anemia was documented in 38 543 patients (48%) and was mild in 27 435 (71%), moderate in 9783 (25%), and severe in 1325 (4%). The median follow-up duration was 4 years (range, 1.25-5.78 years). On univariate analysis, 30 day mortality, total LOS, and overall survival were significantly associated with the level of preoperative anemia. These associations persisted in the multivariate models. Kaplan-Meier survival analysis demonstrated an association of death with degree of anemia (p<0.001). CONCLUSION: The presence and degree of preoperative anemia were independently associated with increased 30 day mortality and LOS and decreased overall survival for patients with peripheral artery disease who had undergone endovascular PVI. CLINICAL IMPACT: The findings from this study have many implications for how to approach vascular surgery in patients with variable hemoglobin levels. Our findings will strengthen our ability to conduct accurate preoperative risk stratification for patients undergoing peripheral vascular interventions. This may also mitigate healthcare expenditures if findings are applied in a way that can lower patient length of postoperative stay while also maintaining quality of care and patient safety. Our results will also serve as guidance for clinical trials, and future prospective trials should evaluate the effect of preoperative optimization of hemoglobin as a potentially modifiable risk factor for outcomes.
引用
- Natour AK, Shepard AD, Nypaver TJ, et al. Impact of Preoperative Anemia on Hospitalization, Death, and Overall Survival in Patients With Peripheral Artery Disease Undergoing Endovascular Therapy: A Retrospective Cohort Study in the United States and Canada. J Endovasc Ther. 2023. PMID: 36680405. doi:10.1177/15266028221149926
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。